Av. Dr. Enéas Carvalho de Aguiar, 44 - 1° andar, sala 2 - Cerqueira César, São Paulo - SP, CEP: 05403-000
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Felipe Gallego Lima
Mateus P Feitosa
Carlos V Serrano
Bruno Caramelli
Bruno Baldi
Luciana Nóbrega
Katiane Oliveira
Mayara Mendes
Open studies
Cardiovascular Disease
Feasibility Study of the Tioga TMVR System - Tioga Cardiovascular, Inc.See more
Cephea South America Feasibility Study - Abbott Medical DevicesSee more
Sleep disorders
Effect of Eszopiclone on Adherence to CPAP and Severity of Insomnia in Patients With COMISA - University of Sao Paulo General HospitalSee more
Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN) - PRYSMA-HTN - Eurofarma Laboratorios S.A.See more
Arterial hypertension
Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN) - PRYSMA-HTN - Eurofarma Laboratorios S.A.See more
Cervical cancer
Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer - AddChemo - Hospital do CoracaoSee more
Chronic obstructive pulmonary disease
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease - ARNASA - Hoffmann-La RocheSee more
Heart failure
ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System - ALT-FLOW II - Edwards LifesciencesSee more
Hpv
Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer - AddChemo - Hospital do CoracaoSee more
Hypercholesterolemia
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029) - Merck Sharp & Dohme LLCSee more
Multiple myeloma
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) - MagnetisMM-32 - PfizerSee more